In Review: Senate Bill 121 (omnibus) underwent its fourth hearing on March 20 in the Senate Labor & Commerce Committee, where bill sponsor Senator Cathy Giessel (R) once again mischaracterized the PBM industry and opposition testimonies. The legislation has garnered both support and criticism from various organizations, with the pharmacy industry providing support testimony at this hearing.

Up Next: The House Labor and Commerce Committee will hold a public hearing on March 25 for invited and general testimony regarding HB 226 (omnibus).

If you have any questions, please contact Bill Head at tsorrell-neal@pcmanet.org.